213 related articles for article (PubMed ID: 19394265)
1. Investigations of clinical isolations of oral poliovirus vaccine strains between 2000 and 2005 in southern Taiwan.
Chi CY; Tseng FC; Liu DP; Chang YW; Wu HC; Huang YF; Hwang KP; Hsu YW; Wang SM; Liu CC; Wu HS; Yang JY; Yang CF; Wang JR; Su IJ
J Clin Virol; 2009 Jun; 45(2):129-34. PubMed ID: 19394265
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa.
Pavlov DN; Van Zyl WB; Van Heerden J; Kruger M; Blignaut L; Grabow WO; Ehlers MM
J Appl Microbiol; 2006 Dec; 101(6):1367-79. PubMed ID: 17105568
[TBL] [Abstract][Full Text] [Related]
3. Oral poliovaccine: will it help eradicate polio or cause the next epidemic?
Shulman LM; Manor Y; Sofer D; Swartz T; Mendelson E
Isr Med Assoc J; 2006 May; 8(5):312-5. PubMed ID: 16805227
[TBL] [Abstract][Full Text] [Related]
4. Clinical features of children infected with different strains of influenza B in southern Taiwan.
Chi CY; Wang SM; Lin CC; Wang HC; Wang JR; Su IJ; Liu CC
Pediatr Infect Dis J; 2008 Jul; 27(7):640-5. PubMed ID: 18520968
[TBL] [Abstract][Full Text] [Related]
5. Site analysis of recombinant and mutant poliovirus isolates of Sabin origin from patients and from vaccinees.
Karakasiliotis I; Markoulatos P; Katsorchis T
Mol Cell Probes; 2004 Apr; 18(2):103-9. PubMed ID: 15051119
[TBL] [Abstract][Full Text] [Related]
6. Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies.
Mas Lago P; Ramon Bravo J; Andrus JK; Comellas MM; Galindo MA; de Quadros CA; Bell E
Bull World Health Organ; 1994; 72(2):221-5. PubMed ID: 8205641
[TBL] [Abstract][Full Text] [Related]
7. Poliovirus vaccine strains detected in stool specimens of immunodeficient children in South Africa.
Pavlov DN; Van Zyl WB; Kruger M; Blignaut L; Grabow WO; Ehlers MM
Diagn Microbiol Infect Dis; 2006 Jan; 54(1):23-30. PubMed ID: 16290028
[TBL] [Abstract][Full Text] [Related]
8. Interrupting wild poliovirus transmission using oral poliovirus vaccine: environmental surveillance in high-risks area of India.
Chowdhary R; Dhole TN
J Med Virol; 2008 Aug; 80(8):1477-88. PubMed ID: 18551602
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of vaccine-derived polioviruses in sewage and river water in South Africa.
Pavlov DN; Van Zyl WB; Van Heerden J; Grabow WO; Ehlers MM
Water Res; 2005 Sep; 39(14):3309-19. PubMed ID: 15996707
[TBL] [Abstract][Full Text] [Related]
10. Three cases of paralytic poliomyelitis associated with type 3 vaccine poliovirus strains in Bulgaria.
Korsun N; Kojouharova M; Vladimirova N; Fiore L; Litvinenko I; Buttinelli G; Fiore S; Voynova-Georgieva V; Mladenova Z; Georgieva D
J Med Virol; 2009 Sep; 81(9):1661-7. PubMed ID: 19626606
[TBL] [Abstract][Full Text] [Related]
11. Genetic features of polioviruses isolated in Tunisia, 1991-2006.
Haddad-Boubaker S; Ben Yahia A; Bahri O; Morel V; Balanant J; Delpeyroux F; Triki H
J Clin Virol; 2008 Feb; 41(2):81-6. PubMed ID: 18023246
[TBL] [Abstract][Full Text] [Related]
12. Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child.
Adu F; Iber J; Bukbuk D; Gumede N; Yang SJ; Jorba J; Campagnoli R; Sule WF; Yang CF; Burns C; Pallansch M; Harry T; Kew O
Virus Res; 2007 Jul; 127(1):17-25. PubMed ID: 17449127
[TBL] [Abstract][Full Text] [Related]
13. Use of mutational pattern in 5'-NCR and VP1 regions of polioviruses for molecular diagnosis.
Pliaka V; Dedepsidis E; Kyriakopoulou Z; Papadopoulou I; Levidiotou S; Markoulatos P
Mol Cell Probes; 2007 Aug; 21(4):267-75. PubMed ID: 17336496
[TBL] [Abstract][Full Text] [Related]
14. Analysis of reversions in the 5'-untranslated region of attenuated poliovirus after sequential administration of inactivated and oral poliovirus vaccines.
Laassri M; Lottenbach K; Belshe R; Rennels M; Plotkin S; Chumakov K
J Infect Dis; 2006 May; 193(10):1344-9. PubMed ID: 16619180
[TBL] [Abstract][Full Text] [Related]
15. [Isolation of recombinant vaccine strains of poliovirus from patients with poliomyelitis].
Kutitova OK; Lipskaia GIu; Maslova SV; Agol VI
Mol Gen Mikrobiol Virusol; 1989 Nov; (11):14-20. PubMed ID: 2560812
[TBL] [Abstract][Full Text] [Related]
16. Genomic features of intertypic recombinant sabin poliovirus strains excreted by primary vaccinees.
Cuervo NS; Guillot S; Romanenkova N; Combiescu M; Aubert-Combiescu A; Seghier M; Caro V; Crainic R; Delpeyroux F
J Virol; 2001 Jul; 75(13):5740-51. PubMed ID: 11390576
[TBL] [Abstract][Full Text] [Related]
17. Neurologic complications associated with oral poliovirus vaccine and genomic variability of the vaccine strains after multiplication in humans.
Friedrich F
Acta Virol; 1998 Jun; 42(3):187-94. PubMed ID: 9842449
[TBL] [Abstract][Full Text] [Related]
18. Recurrent isolation of poliovirus 3 strains with chimeric capsid protein Vp1 suggests a recombination hot-spot site in Vp1.
Blomqvist S; Savolainen-Kopra C; Paananen A; El Bassioni L; El Maamoon Nasr EM; Firstova L; Zamiatina N; Kutateladze T; Roivainen M
Virus Res; 2010 Aug; 151(2):246-51. PubMed ID: 20493912
[TBL] [Abstract][Full Text] [Related]
19. [Genetic recombination in vaccine poliovirus: comparative study in strains excreted in course of vaccination by oral poliovirus vaccine and circulating strains].
Haddad-Boubaker S; Ould-Mohamed-Abdallah MV; Ben-Yahia A; Triki H
Pathol Biol (Paris); 2010 Dec; 58(6):420-5. PubMed ID: 19299091
[TBL] [Abstract][Full Text] [Related]
20. Circulation of a type 1 recombinant vaccine-derived poliovirus strain in a limited area in Romania.
Combiescu M; Guillot S; Persu A; Baicus A; Pitigoi D; Balanant J; Oprisan G; Crainic R; Delpeyroux F; Aubert-Combiescu A
Arch Virol; 2007; 152(4):727-38. PubMed ID: 17195957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
